
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
iSpecimen has announced a new initiative in the battle against COVID-19 and other diseases, mobile phlebotomy support that will bring at-home sample collection to patients and donors interested in advancing research. The mobile service extends iSpecimen’s ongoing mission to advance medical research by connecting researchers with patients, biospecimens, and the data they need to perform their work.
For more information, click






